Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
WOBURN, MA / ACCESSWIRE / December 3, 2024 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic...
Biofrontera Inc. Completes $4.2 Million Private Placement of Senior Secured Convertible Note
Biofrontera completes a $4.2 million secured convertible note private placement to support operations and growth initiatives.Quiver AI SummaryBiofrontera Inc. has announced the completion of a $4.2 million...